PLEASANTON, Calif—The Cooper Companies (NYSE:COO) announced that revenue for the fiscal first quarter ended Jan. 31, 2017 increased 11 percent year-over-year to $499.1 million or 8 percent pro forma.

Commenting on the results, Robert S. Weiss, Cooper's president and CEO said, "We are very pleased to report a strong first quarter. CooperVision continued gaining market share driven by growth in Biofinity and daily silicone hydrogel products while CooperSurgical continued its growth driven by fertility. Our business fundamentals remain strong and we remain excited about the future."

CooperVision (CVI) revenue was $389.3 million, which is up 7 percent from last year’s first quarter and up 9 percent in constant currency. The gross margin was 63 percent compared with 57 percent in last year’s first quarter. On a non-GAAP basis, gross margin was 63 percent from 61 percent last year. Gross margin was positively impacted primarily from positive product mix led by Biofinity.

Sales of toric contact lenses accounted for $120.7 million, up 12 percent from last year’s first quarter and up 14 percent on a constant currency basis. Multifocal contact lenses generated $42.4 million in sales up 5 percent from a year ago and a 7 percent increase in constant currency. Single-use sphere generated sales of $99.5 million, a 10 percent increase from 2016 and a 12 percent increase in constant currency. Non single-use spheres and other lenses accounted for $126.7 million in sales, up 1 percent from a year ago and up 3 percent in constant currency.

CooperSurgical (CSI) posted revenue of $109.8 million, up 29 percent from last year’s quarter and up 3 percent pro forma. Gross margin was 61 percent compared with 63 percent in last year’s first quarter. On a non-GAAP basis, gross margin was 62 percent from 64 percent last year. Gross margin was negatively impacted primarily by lower margin acquisitions.

The total debt increased $90.7 million from Oct. 31, 2016 to $1,424.5 million, primarily due to the acquisition of Wallace partially offset by operation cash flow generation. Cash provided by operations $108.4 million offset by capital expenditures $28.7 million resulted in free cash flow of $79.7 million.